High levels of physical activity are associated with lower levels of fatigue among lymphoma patients: Results from the longitudinal PROFILES registry

Acta Oncologica
Olga HussonL V van de Poll-Franse

Abstract

Studies show a cross-sectional association between physical activity (PA) and fatigue among lymphoma cancer patients. However, few longitudinal studies have examined whether PA has a sustained effect on fatigue over time. To examine the longitudinal relationship between PA and fatigue. All living individuals diagnosed with lymphoma between 1999 and 2010 as registered by the Dutch population-based Eindhoven Cancer Registry received a questionnaire on three time points. Generalized linear mixed models were used to estimate the independent effects of PA on fatigue. PA and fatigue levels did not differ between patients short-term (< 1 year) and long-term after diagnosis (1-5 years or > 5 years). PA behavior was relatively constant over time with 84% of the patients meeting the Dutch PA guidelines at all assessment periods. Fatigue scores also remained fairly stable over time with 46% of the patients never being fatigued and 29% always being fatigued. Multivariate analyses showed that patients who met the PA guidelines scored 6.2 (95% CI 3.1-9.2) points lower on total fatigue over time (between subject effect; p < 0.01), compared to patients not meeting PA guidelines. During a period of two years, PA and fatigue levels were rather s...Continue Reading

References

Sep 19, 2000·Medicine and Science in Sports and Exercise·B E AinsworthA S Leon
Dec 31, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L M OldervollJ H Loge
Apr 3, 2003·Journal of Psychosomatic Research·Helen J MichielsenGuus L Van Heck
Oct 30, 2003·Cancer·Roberto StasiSergio Amadori
Apr 13, 2005·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Kerry S CourneyaAdrian S Fairey
Oct 18, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A K NgL Diller
Oct 13, 2006·Chest·Helen J MichielsenJolanda De Vries
Aug 19, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kerry S CourneyaTony Reiman
Apr 2, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D W VoskuilJ C J M de Haes
Jun 12, 2010·Journal of Pain and Symptom Management·Andrea M BarsevickUNKNOWN ASCPRO (Assessing Symptoms of Cancer Using Patient-Reported Outcomes)
Nov 6, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Justin C BrownBlair T Johnson
May 31, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Lonneke V van de Poll-FranseUNKNOWN Profiles Registry Group
Jul 21, 2012·American Journal of Preventive Medicine·Timothy W Puetz, Matthew P Herring
Dec 19, 2012·Acta Oncologica·Lee W Jones, Catherine M Alfano
Jun 4, 2013·Annals of Hematology·Laurien A DaniëlsCarien L Creutzberg

❮ Previous
Next ❯

Citations

Apr 25, 2015·Acta Oncologica·Christoffer Johansen, Susanne Oksbjerg Dalton
Dec 23, 2017·Journal of Adolescent and Young Adult Oncology·Brittany C KimballCarrie A Thompson
Sep 5, 2018·Journal of Clinical Nursing·Fidelma Hackett, Maura Dowling
Apr 29, 2020·Blood Advances·Andrea SitlingerDavid B Bartlett

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.